(Q45733272)

English

Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect™ versus Veridex CellSearch™ system

scientific article published on 30 November 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 December 2017

Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect™ versus Veridex CellSearch™ system (English)

1 reference

Europe PubMed Central

15 December 2017

metastatic breast cancer

1 reference

based on heuristic

inferred from title

author name string

E Andreopoulou

1

1 reference

Europe PubMed Central

15 December 2017

L-Y Yang

2

1 reference

Europe PubMed Central

15 December 2017

K M Rangel

3

1 reference

Europe PubMed Central

15 December 2017

J M Reuben

4

1 reference

Europe PubMed Central

15 December 2017

L Hsu

5

1 reference

Europe PubMed Central

15 December 2017

S Krishnamurthy

6

1 reference

Europe PubMed Central

15 December 2017

V Valero

7

1 reference

Europe PubMed Central

15 December 2017

H A Fritsche

8

1 reference

Europe PubMed Central

15 December 2017

M Cristofanilli

9

1 reference

Europe PubMed Central

15 December 2017

language of work or name

0 references

publication date

30 November 2011

1 reference

Europe PubMed Central

15 December 2017

International Journal of Cancer

1 reference

Europe PubMed Central

15 December 2017

130

1 reference

Europe PubMed Central

15 December 2017

7

1 reference

Europe PubMed Central

15 December 2017

1590-1597

1 reference

Europe PubMed Central

15 December 2017

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26111

21 January 2018

Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26111

21 January 2018

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26111

21 January 2018

EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26111

21 January 2018

EpCAM: A New Therapeutic Target for an Old Cancer Antigen

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26111

21 January 2018

Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26111

21 January 2018

Expression of luminal and basal cytokeratins in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26111

21 January 2018

Detection and characterization of carcinoma cells in the blood

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26111

21 January 2018

Quantitative real-time RT-PCR of disseminated tumor cells in combination with immunomagnetic cell enrichment

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26111

21 January 2018

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26111

21 January 2018

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26111

21 January 2018

Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26111

21 January 2018

Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26111

21 January 2018

Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26111

21 January 2018

Circulating tumor cells and biomarkers: implications for personalized targeted treatments for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26111

21 January 2018

Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26111

21 January 2018

Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26111

21 January 2018

Prognostic value of genomic alterations in minimal residual cancer cells purified from the blood of breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26111

21 January 2018

HER-2 gene amplification can be acquired as breast cancer progresses

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26111

21 January 2018

uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26111

21 January 2018

Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26111

21 January 2018

Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26111

21 January 2018

Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26111

21 January 2018

Identifiers

10.1002/IJC.26111

1 reference

Europe PubMed Central

15 December 2017

1 reference

Europe PubMed Central

15 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45733272&oldid=2079052785"